Analysis of the spontaneous scratching behavior by NC/Nga mice: A possible approach to evaluate antipruritics for subjects with atopic dermatitis

European Journal of Pharmacology

Volumn 471, Issue 3, 2003, Pages 223-228

  Takano, Norikazu ^a   Arai, Iwao ^a   Kurachi, Michio ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Atopic dermatitis; Itch; MicroAct; NC Nga, mouse; Scratching

Indexed keywords

ANTIPRURITIC AGENT; CHLORPHENIRAMINE; DEXAMETHASONE; HISTAMINE; KETOTIFEN; OVALBUMIN; TACROLIMUS;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATOPIC DERMATITIS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PRURITUS; SCRATCHING; SKIN ANAPHYLAXIS; STATISTICAL SIGNIFICANCE; TECHNIQUE;

EID: 0038771253     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01828-4     Document Type: Article

References (31)

1. Andersson J., Nagy S., Groth C.G., Andersson U. Effects of FK506 and cyclosporin A on cytokine production studied in vitro at a single-cell level. Immunology. 75(1):1992;136-142.
2. 1 tachykinin receptors in mice. J. Pharmacol. Exp. Ther. 286:1998;1140-1145.
3. Assmann T., Homey B., Ruzicka T. Topical tacrolimus for the treatment of inflammatory skin diseases. Expert Opin. Pharmacother. 2(7):2001;1167-1175.
4. Berth-Jones J., Graham-Brown R.A.C. Failure of terfenadine in relieving the pruritus of the atopic dermatitis. Br. J. Dermatol. 121:1989;635-637.
5. Caroline S.K. Itching and the atopic skin. J. Allergy Clin. Immunol. 104:1999;S109-S113.
6. Greaves M.W., Wall P.D. Pathophysiology of itching. Lancet. 348:1996;938-940.
7. Hanifin J.M., Rajka G. Diagnostic features of atopic dermatitis. Acta Derm.-Venereol., Suppl. 92:1980;44-47.
8. Hanifin J.M., Tofte S.J. Update on therapy of atopic dermatitis. J. Allergy Clin. Immunol. 104:1999;S123-S125.
9. Hiroi J. Pharmacological profile and clinical effect of tacrolimus ointment (Protopic ointment) for atopic dermatitis. Folia Pharmacol. Jpn. 117:2001;351-357.
10. Hägermark Ö. Peripheral and central mediators of itch. Skin Pharmacol. 5:1992;1-8.
11. Hägermark Ö., Wahlgren C.-F. Itch in atopic dermatitis: the role of histamine and other mediators and the failure of antihistamine therapy. Dermatol. Ther. 1:1996;75-82.
12. Inagaki N., Nakamura N., Nagao M., Musoh K., Kawasaki H., Nagai H. Participation of histamine H1 and H2 receptors in passive cutaneous anaphylaxis-induced scratching behavior in ICR mice. Eur. J. Pharmacol. 367:1999;361-371.
13. Inagaki N., Igeta K., Kim J.F., Nagao M., Shiraishi N., Nakamura N., Nagai H. Involvement of unique mechanisms in the induction of scratching behavior in BALB/c mice by compound 48/80. Eur. J. Pharmacol. 448:2002;175-183.
14. Kimura T., Miyazawa H. The 'butterfly' sign in patients with atopic dermatitis: evidence for the role of scratching in the development of skin manifestations. J. Am. Acad. Dermatol. 21(3):1989;579-580.
15. Kino T., Hatanaka H., Miyata S., Inamura N., Nishiyama M., Yajima T., Goto T., Okumura M., Kouhsaka M., Aoki H., Ochiai T. FK-506, a novel immunosuppressant isolated from a Streptomyces: II. Immunosuppressive effect of FK-506 in vitro. J. Antibiot. (Tokyo). 40(9):1987;1256-1265.
16. Klein P.A., Clark R.A.F. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch. Dermatol. 135(12):1999;1522-1525.
17. Kondo K., Nagami T., Teramoto S. Differences in haematopoietic death among inbred strains of mice. Bond S.V., Sugahara T. Comparative Cellular and Species Radiosensitivity. 1964;20 Igakushoin, Tokyo.
18. Kuraishi Y., Nagasawa T., Hayashi K., Satoh M. Scratching behavior induced by pruritogenic but not algesiogenic agents in mice. Eur. J. Pharmacol. 275:1995;229-233.
19. Matsuda H., Watanabe N., Geba G.P., Sperl J., Tsudzuki M., Hiroi J., Matsumoto M., Ushio J., Saito S., Askenase P.W., Ra C. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int. Immunol. 9:1997;461-466.
20. Munday J., Bloomfield R., Goldman M., Robey H., Kitowska G.J., Gwiezdziski Z., Wankiewicz A., Marks R., Protas-Ddozd F., Mikaszewska M. Chlorpheniramine is no more effective than placebo in relieving the symptoms of childhood atopic dermatitis with a nocturnal itching and scratching component. Dermatology. 205:2002;40-45.
21. Nakagawa H., Etoh T., Ishibashi Y., Higaki Y., Kawashima M., Torii H., Harada S. Tacrolimus ointment for atopic dermatitis. Lancet. 344:1994;883.
22. Smith E.W. Four decades of topical corticosteroid assessment. Curr. Probl. Dermatol. 22:1995;124-131.
23. Suto H., Matsuda H., Mitsuishi K., Hira K., Uchida T., Unno T., Ogawa H., Ra C. NC/Nga mice: a mouse model for atopic dermatitis. Int. Arch. Allergy Immunol. 120(Suppl. 1):1999;70-75.
24. Tohda C., Yamaguchi T., Kuraishi Y. Increased expression of mRNA for myocyte-specific enhancer binding factor (MEF) 2C in the cerebral cortex of the itching mouse. Neurosci. Res. 29:1997;209-215.
25. Wahlgren C.-F. Pathophysiology of itching in urticaria and atopic dermatitis. Allergy. 47:1992;65-75.
26. Wahlgren C.-F. Itch and atopic dermatitis: an overview. J. Dermatol. 26:1999;770-779.
27. Wahlgren C.-F., Hägermark Ö., Bergström R. Patients' perception of itch induced by histamine, compound 48/80 and wool fibres in atopic dermatitis. Acta Derm.-Venereol. 71:1990;488-494.
28. Wahlgren C.-F., Linder M.T., Hägermark Ö., Scheynius A. Itch and inflammation induced by intradermally injected interleukin-2 in atopic dermatitis patients and healthy subjects. Arch. Dermatol. Res. 287:1995;572-580.
29. Williams H.C., Burney P.G.J., Perbroke A.C., Hay R.J. The U.K. working party's diagnostic criteria for atopic dermatitis: III. Independent hospital validation. Br. J. Dermatol. 131:1994;406-416.
30. 2 receptors in mice. Neurosci. Res. 35:1999;77-83.
31. Yamaguchi T., Maekawa T., Nishikawa Y., Nojima H., Kaneko M., Kawakita T., Miyamoto T., Kuraishi Y. Characterization of itch-associated responses of NC mice with mite-induced chronic dermatitis. J. Dermatol. Sci. 25:2001;20-28.